Caldwell Trust Co Makes New Investment in Intuitive Surgical, Inc. $ISRG

Caldwell Trust Co bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,310 shares of the medical equipment provider’s stock, valued at approximately $1,255,000.

Several other institutional investors have also bought and sold shares of ISRG. Norway Savings Bank boosted its holdings in Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after purchasing an additional 910 shares during the period. Trust Co. of Oklahoma purchased a new stake in shares of Intuitive Surgical in the second quarter worth $363,000. IronOak Wealth LLC. bought a new stake in Intuitive Surgical during the second quarter valued at $1,099,000. Eastover Investment Advisors LLC grew its position in Intuitive Surgical by 204.8% during the second quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock worth $7,153,000 after buying an additional 8,844 shares in the last quarter. Finally, Amalgamated Bank grew its position in Intuitive Surgical by 2.2% during the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after buying an additional 1,772 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $559.52 on Tuesday. The company has a market capitalization of $200.58 billion, a PE ratio of 74.01, a price-to-earnings-growth ratio of 4.98 and a beta of 1.68. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company’s 50 day moving average price is $531.81 and its two-hundred day moving average price is $505.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.84 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the sale, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. UBS Group set a $600.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Finally, Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $608.79.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.